This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (80118)
-
September 26, 2025 | Official Statement EssilorLuxottica wins dismissal of US price-fixing claims
Sections: Antitrust
-
September 26, 2025 | Official Statement Teva files second amended US antitrust complaint against Corcept, Optime
...second amended complaint against Corcept Therapeutics and Optime Care "for pervasive and highly damaging antitrust...
Sections: Antitrust
-
September 26, 2025 | Official Statement Advertisers file reply in support of dismissing X Corp.'s US antitrust claims
...MLex Summary: The World Federation of Advertisers filed a reply in support of its motion to dismiss US antitrust...
Sections: Antitrust
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login